Tampa, Florida, Jul 02, 2019 (GLOBE NEWSWIRE) – Leading provider of tissue diagnostics and cancer care insight solutions, Inspirata AI, announced today its First Annual Executive Exchange, being held from July 31 – August 2, 2019 at the Sapphire Falls Resort at Universal Studios in Orlando, Florida. The conference’s theme is “Practical Advances in Cancer Care & Research: Bringing the Cancer Moonshot Back to Earth” and will bring together thought leaders of varied disciplines to focus on the data, technologies, clinical processes and collaboration needed to propel practical advances in cancer care.
Inspirata AI’s Executive Exchange will feature collaborative discussions from some of the industry’s top thought leaders in areas of oncology, pathology, molecular diagnostics, research, technology, surveillance, health systems, payers and the economic and investment market. “The need to collect patient-consented genomic, pathology, and imaging data and correlate it with clinical data, including epidemiologic, treatment and outcomes data, for all cancer patients, under a single accessible data bank is the number one challenge impeding advances in cancer care,” states Keynote speaker, Michael A. Caligiuri, MD, President, City of Hope National Medical Center – Deana and Steve Campbell Physician-in-Chief Distinguished Chair. “Inspirata AI’s Executive Exchange brings the most recent ideas and developments to enhance data sharing among stakeholders to address this issue.” Dr. Caligiuri will present on the topic of rapid advances in precision technology innovation and sustainable strategies for genetic and molecular medicine.
“The cancer care journey is composed of many disciplines that infrequently get the opportunity to collaborate and understand how they can advance the overall care process for patients. Likewise, clinical and research professionals often lack a complete understanding of the others’ needs and restraints in progressing therapy advancement,” states Satish Sanan, CEO of Inspirata AI. “The Inspirata AI Executive Exchange is designed to present a 360-degree perspective on advancing cancer care in an interactive and engaging format. Inspirata AI believes that communication is at the heart of innovation and facilitating collaboration across the varied disciplines of the cancer care journey is a needed catalyst to treatment innovation.”
“The drive to cure cancer through therapy advancement requires relevant and real-world data from across the cancer care journey. It requires precision data, patient involvement and the ability to surface meaningful insights to all care cycle constituents,” states Greg Tennant, Chief Strategy & Marketing Officer for Inspirata AI. “Our industry has struggled with the ability to surface meaningful data, match patients for clinical trials and legitimize the use of data for the advancement of care. Inspirata AI’s leadership in hosting the Executive Exchange on the advancement of cancer therapy is focused on bridging these gaps to drive real progress.”
The Executive Exchange is an invitation only event for cancer industry thought leaders. If you are a cancer industry thought leader and wish to attend the Executive Exchange, please submit a registration request here for consideration. There are no registration costs for approved attendees and no fees paid to our stellar line-up of speakers. The official social media hashtag for the Inspirata AI Executive Exchange will be #iee2019. The Executive Exchange is not a commercial event.
About Inspirata AI, Inc.
Using our native AI platform that is specifically optimized for oncology, Inspirata AI helps cancer programs identify reportable cancer cases in real time, directly from source documents from clinical systems including AP-LIS, Radiology and HER. Using our end-to-end cancer registry workflow automation solution, healthcare organizations can significantly improve their cancer data casefinding, data abstraction, reporting and data analytics in a single platform thus reducing manual burden, and gain earlier visibility into patients clinical data across their cancer care continuum.
Delivering 99% accuracy and actionable oncology intelligence, Inspirata AI transforms cancer registry operations from a traditional cost center into a strategic asset that can support oncology service line revenue growth, patient retention, accreditation readiness, research initiatives, and informed clinical and business decision-making. Trusted by many large healthcare organizations nationwide, Inspirata AI empowers cancer programs to maximize the value of their oncology data and remove duplicate data entry, enabling the service line to identify more patients quickly, retain more patients within their network, and improve patient outcomes across their cancer care journey.
